Table of Contents
Clinical trials
Development of the model for the non-conformance correction and prevention process in clinical trials | |
T. Yu. Kolodyezna, V. Ye. Dobrova, K. O. Zupanets, O. O. Liapunova | 4-11 |
Efficacy and tolerability of the dietary supplement “Altsinara” in subjects with hypercholesterolemia: a laboratory component of the clinical study | PDF (Українська) |
I. A. Zupanets, A. S. Shalamay, I. A. Otrishko, A. I. Fedosov, S. V. Mіsiurova | 12-18 |
Pre-clinical studies of new drugs
Renal effects of the sulfur-containing aminoacid derivatives (ademetionine, taurin and glutathion) in conditionally healthy animals | |
V. M. Drachuk, I. I. Zamorskii, T. S. Shchudrova, O. M. Goroshko | 20-26 |
The preclinical study of a new nasal spray with the anti-inflammatory properties: the effect on the leukotriene-induced inflammation | |
T. S. Zhulai | 27-33 |
Variability of the effect of atristamine and imipramine on the depressive behavior of mice in the aspect of circadian factors | PDF (Українська) |
I. M. Podolsky, S. Yu. Shtrygol’, V. V. Tsyvunin | 34-41 |
The antiexudative action of the plant extract “Venosten” | PDF (Українська) |
A. L. Zagayko, O. S. Kukhtenko, L. V. Galuzinska | 42-45 |
The experimental study of the local irritating action of N-acetylglucosamine and quercetin in intramuscular administration | PDF (Українська) |
S. K. Shebeko, A. S Shalamay, O. O. Liapunova | 46-51 |
The evaluation of the effect of the drug “Arthritan” on the morphofunctional state of the internal organs of rats under the conditions of the chronic toxicity study | PDF (Українська) |
Yu. M. Naboka, N. P. Zubitska, S. K. Shebeko, I. A. Otrishko | 52-57 |
Pharmacoeconomics
The study of the assortment, accessibility and consumption of diuretics in Ukraine | PDF (Українська) |
O. V. Tkachоva, I. V. Kravchenko, A. M. Semenov | 58-64 |